FOSUN PHARMA: Overseas Regulatory Announcement - Announcement Regarding the Release of Pledged Shares by Shareholders
FOSUN PHARMA: Overseas Regulatory Announcement - Announcement on the Renewal of Loans by Subsidiaries and Related Party Transactions
FOSUN PHARMA: Overseas Regulatory Announcement - Announcement in Relation to the Acceptance of a Subsidiary's Drug Registration Application
FOSUN PHARMA: Overseas regulatory announcement - Announcement regarding the holding subsidiary's approval for pharmaceutical registration.
FOSUN PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2024
FOSUN PHARMA: Overseas Regulatory Announcement - Announcement Regarding the Release of Pledged Shares by Shareholders
FOSUN PHARMA: Overseas Regulatory Announcement - Announcement in Relation to the Approval for Drug Registration of a Licensed Product
FOSUN PHARMA: NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK
FOSUN PHARMA: NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK
FOSUN PHARMA: NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK
FOSUN PHARMA: Overseas regulatory announcement - Regarding the progress of the merger and privatization of the holding subsidiary henlius Biotech Co., Ltd. in shanghai.
FOSUN PHARMA: Overseas regulatory announcement - Announcement on the implementation progress of the co-investment of the holding subsidiary and related trade.
FOSUN PHARMA: Overseas Regulatory Notice - Announcement on the Progress of Providing Guarantees to Subsidiaries
FOSUN PHARMA: JOINT ANNOUNCEMENT - PROGRESS UPDATE IN RELATION TO THE PRE-CONDITIONAL PRIVATISATION OF HENLIUS BY FOSUN NEW MEDICINE BY WAY OF MERGER BY ABSORPTION OF HENLIUS
FOSUN PHARMA: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
FOSUN PHARMA: Overseas Regulatory Notice - Announcement on the Progress of Providing Guarantees to Subsidiaries
FOSUN PHARMA: Overseas Regulatory Announcement - Announcement in Relation to the Acceptance of a Subsidiary's Drug Registration Application
FOSUN PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2024
FOSUN PHARMA: NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK
FOSUN PHARMA: Overseas Regulatory Notice - Announcement on the Progress of Providing Guarantees to Subsidiaries
No Data
No Data